Eve Air Mobility Secures $150 Million to Advance eVTOL Development and Urban Air Mobility

Eve Air Mobility Secures Financing to Propel eVTOL Development

Eve Air Mobility (NYSE: EVEX, EVEXW; B3: EVEB31), a leader in electric vertical take-off and landing (eVTOL) technologies, successfully secures $150 million in debt financing from a consortium of noteworthy financial institutions, including Itau, Banco do Brasil, Citibank, and Mitsubishi UFJ Financial Group. This five-year loan underscores the strong investor confidence in Eve’s long-term vision for the urban air mobility landscape, as highlighted by CFO Eduardo Couto. The funding is earmarked for enhancing Eve’s research and development capabilities, facilitating the integration of its eVTOL aircraft into urban infrastructure, and aiding in aircraft certification and commercialization, aligning with global aviation standards.

This financing round elevates Eve’s total capital raised to an impressive $1.2 billion, solidifying its status as one of the most well-capitalized entities in the rapidly evolving eVTOL market. The company recently achieved a significant milestone with the successful first flight of its full-scale engineering prototype at Embraer's test facility in Brazil. This flight validates critical systems such as fly-by-wire controls and energy management, paving the way for a comprehensive testing campaign planned for 2026. Eve's proactive approach to establishing a strong network of suppliers, customers, and strategic partners positions the company favorably in the competitive urban air mobility sector.

Eve's commitment to sustainable growth is evident in its collaborative strategies designed to address the increasing demand for low-emission transportation solutions. As a key player in the U.S. Urban Air Mobility landscape, Eve is poised to make a significant impact on the future of transportation, contributing to the development of an integrated eVTOL ecosystem. With the backing of substantial financial resources and innovative technology, Eve Air Mobility is on a trajectory to reshape urban commuting and aviation, meeting the challenges of modern transportation needs.

In other industry developments, Infinitopes, a clinical-stage cancer vaccine biotechnology company, recently raised an additional $15.4 million in seed financing, bringing its total to $35.1 million. This funding will support its first-in-human clinical trial of a precision cancer vaccine aimed at preventing recurrence in oesophageal cancer, highlighting the increasing relevance of innovative healthcare solutions.

Additionally, doTERRA has appointed Steve Powell as Executive Vice President of Innovation and Advanced Development, focusing on integrating intelligent technology into next-generation wellness devices. With his extensive experience in developing innovative technologies, Powell’s role is expected to enhance doTERRA’s commitment to advancing personal well-being and health through innovation.